These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 23886268)
1. [Magnetic resonance imaging findings of Chromophobe renal cell carcinoma]. Wang XK; Wang HY; Wang J; Wang YW; Wang Y; Tang YH; Ye HY Zhonghua Yi Xue Za Zhi; 2013 Apr; 93(13):1016-9. PubMed ID: 23886268 [TBL] [Abstract][Full Text] [Related]
2. [MR appearance of multifocal clear cell renal cell carcinoma]. Wang HY; Ye HY; Yuan J; Ma L; Zhang X; Tang YH Zhonghua Yi Xue Za Zhi; 2013 Jul; 93(27):2161-3. PubMed ID: 24284252 [TBL] [Abstract][Full Text] [Related]
3. Renal cell carcinoma: dynamic contrast-enhanced MR imaging for differentiation of tumor subtypes--correlation with pathologic findings. Sun MR; Ngo L; Genega EM; Atkins MB; Finn ME; Rofsky NM; Pedrosa I Radiology; 2009 Mar; 250(3):793-802. PubMed ID: 19244046 [TBL] [Abstract][Full Text] [Related]
4. Utility of MRI features in differentiation of central renal cell carcinoma and renal pelvic urothelial carcinoma. Wehrli NE; Kim MJ; Matza BW; Melamed J; Taneja SS; Rosenkrantz AB AJR Am J Roentgenol; 2013 Dec; 201(6):1260-7. PubMed ID: 24261365 [TBL] [Abstract][Full Text] [Related]
5. Diffusion-weighted magnetic resonance imaging in evaluation of primary solid and cystic renal masses using the Bosniak classification. Inci E; Hocaoglu E; Aydin S; Cimilli T Eur J Radiol; 2012 May; 81(5):815-20. PubMed ID: 21377306 [TBL] [Abstract][Full Text] [Related]
6. Usefulness of diffusion-weighted imaging in the evaluation of renal masses. Sandrasegaran K; Sundaram CP; Ramaswamy R; Akisik FM; Rydberg MP; Lin C; Aisen AM AJR Am J Roentgenol; 2010 Feb; 194(2):438-45. PubMed ID: 20093607 [TBL] [Abstract][Full Text] [Related]
7. Diffusion-weighted MRI in renal cell carcinoma: a surrogate marker for predicting nuclear grade and histological subtype. Goyal A; Sharma R; Bhalla AS; Gamanagatti S; Seth A; Iyer VK; Das P Acta Radiol; 2012 Apr; 53(3):349-58. PubMed ID: 22496427 [TBL] [Abstract][Full Text] [Related]
8. [MRI findings of renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions]. Zhong Y; Wang HY; Chen X; Guo AT; Ma L; Wang YW; Ye HY Zhonghua Yi Xue Za Zhi; 2016 Sep; 96(33):2635-2639. PubMed ID: 27666883 [No Abstract] [Full Text] [Related]
9. The correlation between size of renal cell carcinoma and its histopathological characteristics: a single center study of 1867 renal cell carcinoma cases. Zhang C; Li X; Hao H; Yu W; He Z; Zhou L BJU Int; 2012 Dec; 110(11 Pt B):E481-5. PubMed ID: 22540142 [TBL] [Abstract][Full Text] [Related]
10. [MR imaging features of different renal cell carcinoma subtypes]. Wu B; Peng WJ; Gu YJ; Yang TX; Jiang ZX; Zhang HL; Dai B; Ye DW; Kong YY; Du X Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):825-30. PubMed ID: 19173827 [TBL] [Abstract][Full Text] [Related]
11. MRI features of renal oncocytoma and chromophobe renal cell carcinoma. Rosenkrantz AB; Hindman N; Fitzgerald EF; Niver BE; Melamed J; Babb JS AJR Am J Roentgenol; 2010 Dec; 195(6):W421-7. PubMed ID: 21098174 [TBL] [Abstract][Full Text] [Related]
12. [Clinical features on chromophobe renal cell carcinoma]. Wang ZH; DU LH; Hu ZQ; Chen XG; Zhao X; Wang SG; Zhuang QY; Ye ZQ Zhonghua Wai Ke Za Zhi; 2011 Apr; 49(4):320-3. PubMed ID: 21612697 [TBL] [Abstract][Full Text] [Related]
13. Renal cell carcinoma: diffusion-weighted MR imaging for subtype differentiation at 3.0 T. Wang H; Cheng L; Zhang X; Wang D; Guo A; Gao Y; Ye H Radiology; 2010 Oct; 257(1):135-43. PubMed ID: 20713607 [TBL] [Abstract][Full Text] [Related]
14. [Comparison of MRI manifestations and histopathologic findings in pancreatic head carcinoma in vivo ex vivo]. Wang DQ; Zeng MS; Shi X; Ji Y; Jin DY; Lou WH; Chen CZ; Li RC; Shen JZ Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):347-51. PubMed ID: 18953833 [TBL] [Abstract][Full Text] [Related]
15. Utility of the apparent diffusion coefficient for distinguishing clear cell renal cell carcinoma of low and high nuclear grade. Rosenkrantz AB; Niver BE; Fitzgerald EF; Babb JS; Chandarana H; Melamed J AJR Am J Roentgenol; 2010 Nov; 195(5):W344-51. PubMed ID: 20966299 [TBL] [Abstract][Full Text] [Related]
16. [A comparative study of MRI manifestations and pathological changes in hepatocellular carcinoma treated by transcatheter arterial chemoembolization with lipiodol]. Liu R; Wang JH; Zhou KR; Yan FH; Yan ZP; Shen JZ; Tan YS; Cai Y Zhonghua Gan Zang Bing Za Zhi; 2005 Oct; 13(10):754-8. PubMed ID: 16248948 [TBL] [Abstract][Full Text] [Related]
17. Predicting the histology of small renal masses using preoperative dynamic contrast-enhanced magnetic resonance imaging. Kim JH; Bae JH; Lee KW; Kim ME; Park SJ; Park JY Urology; 2012 Oct; 80(4):872-6. PubMed ID: 22854134 [TBL] [Abstract][Full Text] [Related]
18. Small renal masses: assessment of lesion characterization and vascularity on dynamic contrast-enhanced MR imaging with fat suppression. Scialpi M; Di Maggio A; Midiri M; Loperfido A; Angelelli G; Rotondo A AJR Am J Roentgenol; 2000 Sep; 175(3):751-7. PubMed ID: 10954462 [TBL] [Abstract][Full Text] [Related]
19. [Characterization and staging of renal tumors: significance of MRI diagnostics]. Kalinka A; Gerlach A; Arlart IP; Günes N; Hauser TK; Würstlin S; Bosse A Rofo; 2006 Mar; 178(3):298-305. PubMed ID: 16508837 [TBL] [Abstract][Full Text] [Related]
20. Small renal tumors: correlation of clinical and pathological features with tumor size. Pahernik S; Ziegler S; Roos F; Melchior SW; Thüroff JW J Urol; 2007 Aug; 178(2):414-7; discussion 416-7. PubMed ID: 17561161 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]